Voyageur Pharmaceuticals Ltd.
VYYRF
$0.0991
-$0.0069-6.51%
| 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | 08/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -261.00K | -412.70K | -244.80K | -206.80K | -91.50K |
| Total Depreciation and Amortization | 300.00 | 300.00 | 300.00 | 400.00 | 400.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.80K | 180.30K | 94.00K | 42.30K | -32.70K |
| Change in Net Operating Assets | 236.80K | 93.20K | 14.30K | 185.80K | 60.80K |
| Cash from Operations | -8.10K | -138.90K | -136.30K | 21.70K | -62.90K |
| Capital Expenditure | -40.20K | -28.00K | -27.90K | -24.30K | -41.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -40.20K | -28.00K | -27.90K | -24.30K | -41.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.60K | -- | 493.60K | -- | 16.40K |
| Repurchase of Common Stock | -- | -5.60K | -- | -12.50K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 50.30K | -3.60K | -25.30K | 16.40K | 0.00 |
| Cash from Financing | 40.80K | -6.70K | 348.60K | 2.80K | 12.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -7.40K | -173.60K | 184.30K | 100.00 | -91.70K |
